Life Scientist > Biotechnology

Wearable injector can detect, reverse opioid overdose

25 November, 2021

The device, worn on the stomach, senses when a person stops breathing and injects naloxone — a lifesaving antidote that can restore respiration.


Penicillin helps treat rheumatic heart disease in children

18 November, 2021

A regular, affordable antibiotic treatment has been found to significantly reduce the risk of underlying rheumatic heart disease progression in children.


Gold nanoparticles help treat prostate cancer patients

16 November, 2021

The treatment can make cancerous cells up to 30% more receptive to radiotherapy while simultaneously reducing adverse side effects that limit quality of life.


Smart bandage enables onsite chronic wound monitoring

08 November, 2021

The smart wearable sensor can conduct real-time, point-of-care assessment of chronic wounds wirelessly via an app.


TGA approves Pfizer COVID-19 booster vaccine for Aus adults

27 October, 2021 by Lauren Davis

The TGA provisionally approves a booster dose of Pfizer's vaccine for individuals 18 years and older, while advisers to the US FDA recommend the vaccine for children aged 5–11.


RNA pilot manufacturing facility announced for NSW

22 October, 2021

The $96 million pilot facility will develop mRNA and RNA drugs and vaccines, in order to better combat disease and save lives.


Outsourcing single-use technologies to accelerate speed to market

21 October, 2021

To fast-track time to market and gain a competitive edge, pharmaceutical development companies are increasingly implementing single-use technologies.


Empowering researchers to develop genetic medicines

18 October, 2021

The Precision Nanosystems NanoAssemblr is a platform of technologies designed to encapsulate a drug or genetic material.


Intestinal drug found to boost memory and cognition

15 October, 2021

An existing drug — used to treat constipation — may be able to boost our ability to think more clearly.


Aus buys 300K courses of Merck's oral COVID-19 treatment

06 October, 2021

The Australian Government will purchase 300,000 courses of the company's promising oral COVID-19 treatment, should it receive approval from the TGA.


Antidepressants found to inhibit tumour growth in mice

05 October, 2021

When combined with immunotherapy the drugs managed to stop the cancer growth long term, and in some cases the tumours disappeared completely.


Monash Uni to launch Victoria's Health Innovation Centre

24 September, 2021

The Health Innovation Centre will include a flagship cardiovascular disease-focused research accelerator, HeartLabs, and a new focal point for clinical trials.


ATAGI recommends Moderna for teens, extra doses secured

13 September, 2021 by Lauren Davis

The Australian Government has secured an additional one million doses of Moderna's COVID-19 vaccine, recently approved for adolescents aged 12 to 17 years.


Creating a genetic medicine manufacturing ecosystem: part 2

06 September, 2021 by Peter Davis

The landscape has shifted from a hopeless pipedream to firm steps and to the creation of such an ecosystem, from the unlikeliest places.


Aus teens now eligible for Pfizer, TGA approves antibody treatment

30 August, 2021 by Lauren Davis

Pfizer's COVID-19 vaccine will soon be available for all Australians 12 years and above, and the TGA grants provisional approval for a novel monoclonal antibody treatment.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd